Improving Alzheimer's stage categorization with Convolutional Neural Network using transfer learning and different magnetic resonance imaging modalities
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Dec 01, 2020
- Source ID
- 10.1016/j.heliyon.2020.e05652
Entities
People
- Gwénaëlle Catheline
- Jenny Benois-Pineau
- Karim Aderghal
- Karim Afdel
Organizations
- AbbVie
- Alzheimer's Association
- Alzheimer's Drug Discovery Foundation
- BioClinica
- Biogen
- Canadian Institutes of Health Research
- Chiron Corporation
- Eli Lilly and Company
- Foundation for the National Institutes of Health
- GE HealthCare
- Hoffmann-La Roche
- Johnson & Johnson Pharmaceutical Research and Development
- Laboratoires Servier
- Lundbeck
- Merck & Co.
- Meso Scale Diagnostics (United States)
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- Northern California Institute for Research and Education
- Pfizer
- Roche (United States)
- Takeda Pharmaceutical Company
- United States Department of Defense